Correlation Between Pfizer and FinTech Evolution
Can any of the company-specific risk be diversified away by investing in both Pfizer and FinTech Evolution at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and FinTech Evolution into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and FinTech Evolution Acquisition, you can compare the effects of market volatilities on Pfizer and FinTech Evolution and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of FinTech Evolution. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and FinTech Evolution.
Diversification Opportunities for Pfizer and FinTech Evolution
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and FinTech is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and FinTech Evolution Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FinTech Evolution and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with FinTech Evolution. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FinTech Evolution has no effect on the direction of Pfizer i.e., Pfizer and FinTech Evolution go up and down completely randomly.
Pair Corralation between Pfizer and FinTech Evolution
If you would invest 2,550 in Pfizer Inc on September 12, 2024 and sell it today you would lose (27.00) from holding Pfizer Inc or give up 1.06% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 0.4% |
Values | Daily Returns |
Pfizer Inc vs. FinTech Evolution Acquisition
Performance |
Timeline |
Pfizer Inc |
FinTech Evolution |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and FinTech Evolution Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and FinTech Evolution
The main advantage of trading using opposite Pfizer and FinTech Evolution positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, FinTech Evolution can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FinTech Evolution will offset losses from the drop in FinTech Evolution's long position.Pfizer vs. Victory Integrity Smallmid Cap | Pfizer vs. Hilton Worldwide Holdings | Pfizer vs. NVIDIA | Pfizer vs. JPMorgan Chase Co |
FinTech Evolution vs. Zijin Mining Group | FinTech Evolution vs. National CineMedia | FinTech Evolution vs. Skechers USA | FinTech Evolution vs. Eastern Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |